Skip to main content
Livermore
Livermore
ZHEN

Fulcrum Therapeutics, Inc.

FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680581

In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Fulcrum Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of FULC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1011110+10
Shares36.6M95.1K37.2M+742.8K (+2.0%)
Value$1.03B$2.68M$657.3M−$371.6M (−36.1%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to FULC in Q4 2021
InstitutionSharesValue% of portfolio
Holocene Advisors, LP864,978$15.3M0.08%
Deep Track Capital, LP750,000$13.3M0.98%
Logos Global Management LP685,000$12.1M1.25%
Monashee Investment Management LLC273,045$4.83M1.19%
HighVista Strategies LLC89,963$1.59M1.27%
International Biotechnology Trust PLC61,000$1.08M0.24%
Swiss National Bank56,200$994.0K0.00%
HarbourVest Partners LLC39,511$699.0K0.09%
Cinctive Capital Management LP36,120$639.0K0.03%
Prudential Financial Inc28,770$509.0K0.00%
AlphaCentric Advisors LLC28,500$504.0K0.15%
UNC Management Company, Inc.23,708$419.0K0.31%
Ergoteles LLC21,400$379.0K0.01%
Alpine Global Management, LLC20,905$370.0K0.05%
Old Mission Capital LLC20,670$366.0K0.02%
Squarepoint Ops LLC19,229$340.0K0.00%
Credit Suisse AG18,752$332.0K0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.16,742$298.0K0.00%
Gyon Technologies Capital Management, LP15,534$275.0K0.05%
AQR Capital Management LLC14,024$248.0K0.00%
Ensign Peak Advisors, Inc14,970$233.0K0.00%
Rafferty Asset Management, LLC12,971$229.0K0.00%
Balyasny Asset Management LLC11,734$208.0K0.00%
Boulder Hill Capital Management LP11,600$205.0K0.20%
Jump Financial, LLC10,882$193.0K0.01%
Virtus ETF Advisers LLC10,059$178.0K0.07%
Allspring Global Investments Holdings, LLC5,872$103.0K0.00%
Denali Advisors LLC3,900$69.0K0.03%
Zurcher Kantonalbank (Zurich Cantonalbank)2,655$47.0K0.00%
Point72 Hong Kong Ltd982$17.0K0.00%
State of Wyoming749$13.0K0.01%
National Bank of Canada460$8.00K0.00%
PrairieView Partners, LLC200$4.00K0.00%
Toronto Dominion Bank3$00.00%

Sold out (24)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of FULC in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Cowen and Company, LLC1,560,563$44.0M
Boxer Capital, LLC1,250,000$35.3M
Natixis250,000$7.11M
Silverarc Capital Management, LLC185,691$5.24M
Platinum Investment Management Ltd152,186$4.29M
Renaissance Technologies LLC133,900$3.78M
EAM Global Investors LLC78,384$2.21M
Susquehanna Fundamental Investments, LLC57,726$1.63M
EAM Investors, LLC55,383$1.56M
Ghost Tree Capital, LLC50,000$1.41M
Voloridge Investment Management, LLC30,533$861.0K
LMR Partners LLP30,000$846.0K
Verition Fund Management LLC20,000$564.0K
ClariVest Asset Management LLC19,700$556.0K
Mass General Brigham, Inc15,860$447.0K
PDT Partners, LLC13,523$381.0K
Bank of Montreal11,501$325.0K
Jacobs Levy Equity Management, Inc7,487$211.0K
Paradigm Financial Advisors, LLC7,375$208.0K
Group One Trading, L.P.4,973$140.0K
Blackstone Group Inc.4,758$134.0K
Penserra Capital Management LLC925$26.0K
Advisor Group Holdings, Inc.300$8.00K
Federated Hermes, Inc.71$2.00K

Not filed for Q4 2021 yet (1)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FULC in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.95,104$2.68M